Clinical Trial Update: Sodium Selenite as a Cytotoxic Agent in Advanced Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

This document outlines an early-phase clinical trial evaluating sodium selenite as a cytotoxic agent in advanced carcinoma (Phase 1/Phase 2). The status of the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Carcinoma

Drugs mentioned

• Sodium selenite (sodium selenite)

Snippet

Sponsor: Karolinska University Hospital | Conditions: Malignant Tumor, Treatment Resistant Disorders | Phase 1, Phase 2 | Status: UNKNOWN